Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes-Reference-Cited by-同舟云学术

Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes

Published:2001-09 Issue:9 Volume:7 Page:1057-1062
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Sharif Shayan,Arreaza Guillermo A.,Zucker Peter,Mi Qing-Sheng,Sondhi Jitin,Naidenko Olga V.,Kronenberg Mitchell,Koezuka Yasuhiko,Delovitch Terry L.,Gombert Jean-Marc,Leite-de-Moraes Maria,Gouarin Christine,Zhu Ren,Hameg Agathe,Nakayama Toshinori,Taniguchi Masaru,Lepault Françoise,Lehuen Agnès,Bach Jean-François,Herbelin André

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm0901-1057.pdf

Reference33 articles.

1. Delovitch, T.L. & Singh, B. The nonobese diabetic mouse as a model of autoimmune diabetes: Immune dysregulation gets the NOD. Immunity 7, 727–738 (1997).

2. Sonoda, K.H., Exley, M., Snapper, S., Balk, S.P. & Stein-Streilein, J. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site. J. Exp. Med. 190, 1215–1226 (1999).

3. Godfrey, D.I., Hammond, K.J., Poulton, L.D., Smyth, M.J. & Baxter, A.G. NKT cells: facts, functions and fallacies. Immunol. Today 21, 573–83 (2000).

4. Yoshimoto, T. & Paul, W.E. CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 179, 1285–1295 (1994).

5. Sonoda K.H. et al. NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance. J. Immunol. 166, 42–50 (2001).

Cited by 548 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Probiotic treatment with viable α‐galactosylceramide‐producing Bacteroides fragilis reduces diabetes incidence in female nonobese diabetic mice;Journal of Diabetes;2024-08

2. The immune system in neurological diseases: What innate-like T cells have to say;Journal of Allergy and Clinical Immunology;2024-04

3. Recent advances regarding the potential roles of invariant natural killer T cells in cardiovascular diseases with immunological and inflammatory backgrounds;International Immunology;2024-04-01

4. Invariant natural killer T cells in autoimmune cholangiopathies: Mechanistic insights and therapeutic implications;Autoimmunity Reviews;2024-02

5. Therapeutic potential of tolerance-based peptide vaccines in autoimmune diseases;International Immunopharmacology;2023-03